Abstract

Sonic hedgehog (Shh) signaling is critical during normal development, and the abnormal activation of the Shh pathway is involved in many human cancers. As a target gene of the Shh pathway and as a transcription activator downstream of Shh signaling, Gli1 autoregulates and increases Shh signaling output. Gli1 is one of the key oncogenic factors in Shh-induced tumors such as medulloblastoma. Gli1 is posttranslationally modified, but the nature of the active form of Gli1 was unclear. Here we identified a Src family kinase Hck as a novel activator of Gli1. In Shh-responsive NIH3T3 cells, Hck interacts with Gli1 and phosphorylates multiple tyrosine residues in Gli1. Gli1-mediated target gene activation was significantly enhanced by Hck with both kinase activity-dependent and -independent mechanisms. We provide evidence showing that Hck disrupts the interaction between Gli1 and its inhibitor Sufu. In both NIH3T3 cells and cerebellum granule neuron precursors, the Hck gene is also a direct target of Gli1. Therefore, Gli1 and Hck form a positive feedback loop that amplifies Shh signaling transcription outcomes. In Shh-induced medulloblastoma, Hck is highly expressed and Gli1 is tyrosine phosphorylated, which may enhance the tumorigenic effects of the Gli1 oncogene. RNAi-mediated inhibition of Hck expression significantly repressed medulloblastoma cell growth. In summary, a novel positive feedback loop contributes to maximal Gli1 oncogenic activities in Shh-induced tumors such as medulloblastoma.

Highlights

  • In an experiment using RNA-seq designed to identify Sonic hedgehog (Shh)-responsive genes in mouse embryonic fibroblasts (MEFs), we observed that Hck expression was induced by Shh treatment.[39]

  • As Hck is a target gene of Gli[1] and it encodes an activator of Gli[1], Hck and Gli[1] form a positive feedback loop that amplifies Shh signaling outcomes

  • Recent genomic studies on the basis of the transcription profiles have shown that ~ 25% of medulloblastoma cases are characterized by active Shh signaling

Read more

Summary

Introduction

Sonic hedgehog (Shh) signaling has critical roles in many development processes, and dysregulation of Shh signaling has been implicated in diseases and cancers such as those in cerebellum, skin, pancreas, prostate and lung.[1,2,3,4,5,6] In cerebellum during early postnatal development, Shh secreted from Purkinje neurons functions as a mitogen to stimulate the proliferation of cerebellum granular neuron precursor (CGNP) cells.[7,8,9,10] Mutations leading to constitutively active Shh signaling in CGNPs cause CGNP over-proliferation and Shh-type medulloblastoma, which accounts for 25% of all medulloblastoma cases and is the most frequent malignant childhood brain tumor.[11,12,13,14,15] Shh signaling transduced by Patched (Ptch1) and Smoothened (Smo) induces target gene expression by activating Gli transcription activators.[1,3,16,17] Gli[1] is a sensitive Shh target gene and functions solely as a transcription activator in response to Shh signaling. Understanding the largely unknown mechanisms of Gli[1] activation will provide insights into the mechanism of cancer growth and will guide development of treatments.[22,23]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call